Meeting ReportMEDICINE

Signal Transduction Molecules as Targets for Cancer Prevention

See allHide authors and affiliations

Science Signaling  24 Feb 2009:
Vol. 2, Issue 59, pp. mr2
DOI: 10.1126/scisignal.259mr2

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

A report on the joint 3rd Hormel Institute Frontiers in Cancer Conference and 8th International Skin Carcinogenesis Conference held at The Hormel Institute, University of Minnesota, Austin, Minnesota, 4 to 7 October 2008.


Environmental and life-style aspects are major contributors to human carcinogenesis and, therefore, many human cancers may be preventable. Cancer is the end result of defects in cellular signaling processes that play a key role in the control of cell growth, survival, division, and differentiation. Therefore, identifying molecular and cellular targets critical in cancer development and prevention is an area of intensive research, driving the development of highly specific small-molecule inhibitors. A major idea today is that cancer may be prevented or treated by targeting the products of specific cancer-related genes, frequently encoding signaling proteins or transcription factors. Participants in these joint conferences discussed their latest findings in the identification of promising molecular targets and the development of agents directed against these targets with the goal of effectively transitioning these into the clinical setting.

View Full Text

Stay Connected to Science Signaling